A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis
Abstract An increased incidence of narcolepsy type 1 (NT1) was observed in Scandinavia following the 2009–2010 influenza Pandemrix vaccination. The association between NT1 and HLA-DQB1*06:02:01 supported the view of the vaccine as an etiological agent. A/H1N1 hemagglutinin (HA) is the main antigenic...
Guardado en:
Autores principales: | Alexander Lind, Ilaria Marzinotto, Cristina Brigatti, Anita Ramelius, Lorenzo Piemonti, Vito Lampasona |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c358f025cd74411b88b17b1ed5fac4f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis
por: Ilaria Marzinotto, et al.
Publicado: (2021) -
Gut Microbiota in Patients with Type 1 Narcolepsy
por: Zhang R, et al.
Publicado: (2021) -
A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets.
por: Akila Jayaraman, et al.
Publicado: (2011) -
Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus.
por: Jessica A Belser, et al.
Publicado: (2011) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
por: Vellieux G, et al.
Publicado: (2021)